I've been having some trouble understanding my recent test results. My total bilirubin level has been over 1.5 and my SGOTSGPT levels above 50 since September 2015. I've had all sorts of tests done at MIOT, but everything came back negative. The doctors haven't figured out why it's like this yet, and they're suggesting continued follow-up. I'm just really concerned and would appreciate any advice on what might be going on.

Dr Dr Khaleel Ur Rahim

General Practitioner

• MBBS
• 1+ Yrs

Consult Now

Udiliv 300 for Altered Liver Enzymes

Safety and Efficacy

1. Udiliv 300: Contains ursodeoxycholic acid (UDCA), which helps stabilize liver cell membranes and promote bile flow.
2. Short-term use: Generally safe and effective for short-term use (up to 6-12 months) in patients with mild liver enzyme elevations.
3. Long-term use: Long-term safety and efficacy data are limited. Potential risks include:
   • Hepatotoxicity (rare)
   • Increased risk of liver cancer (theoretical)

Precautions and Monitoring

1. Regular liver function tests (LFTs): Monitor LFTs (SGOT, SGPT, and bilirubin) every 3-6 months to assess treatment efficacy and potential hepatotoxicity.
2. Dose adjustment: Adjust the dose or discontinue Udiliv 300 if LFTs worsen or if you experience adverse effects.
3. Liver ultrasound or imaging: Consider periodic liver ultrasound or imaging studies to monitor liver health.

Alternative Options

1. Consult a gastroenterologist or hepatologist: Discuss alternative treatment options and long-term management strategies with a specialist.
2. Lifestyle modifications: Implement lifestyle changes, such as:
   • Maintaining a healthy weight
   • Exercising regularly
   • Eating a balanced diet
   • Avoiding hepatotoxic substances (e.g., excessive alcohol)

In Conclusion

While Udiliv 300 can be used for short-term management of altered liver enzymes, long-term use requires careful monitoring and consideration of alternative options. Consult a specialist to determine the best course of treatment for your specific situation.

Answered 04/07/2025